Related Experiment Videos
Neurotrophin-3 modulates noradrenergic neuron function and opiate withdrawal
1Whitehead Institute for Biomedical Research, Cambridge, MA, USA.
Molecular Psychiatry
|August 30, 2001
Summary
Neurotrophin-3 (NT-3) deficiency in the central nervous system (CNS) impacts opiate withdrawal symptoms by altering noradrenergic signaling. Restoring NT-3 in specific neurons can reverse these effects, highlighting NT-3
Area of Science:
- Neuroscience
- Molecular Biology
- Pharmacology
Background:
- Noradrenergic signaling regulates somatic symptoms and aversion associated with opiate withdrawal.
- Neurotrophin-3 (NT-3) plays a role in neuronal development and function, but its specific role in opiate withdrawal is not fully understood.
Purpose of the Study:
- To investigate the role of endogenous neurotrophin-3 (NT-3) in regulating noradrenergic signaling during opiate withdrawal.
- To determine the effects of conditional ablation of NT-3 in the central nervous system (CNS) on opiate withdrawal behaviors in mice.
Main Methods:
- Conditional ablation of NT-3 in the CNS of mice.
- Assessment of somatic symptoms and aversion related to opiate withdrawal.
- Analysis of cAMP-mediated excitation and tyrosine hydroxylase (TH) expression in the locus coeruleus (A6).
- Restoration of NT-3 expression in noradrenergic neurons.
Main Results:
- CNS-wide conditional ablation of NT-3 attenuated somatic symptoms and aversion of opiate withdrawal.
- This attenuation was associated with altered cAMP-mediated excitation and reduced TH upregulation in the locus coeruleus without neuronal loss.
- Transgene-derived NT-3 expression in noradrenergic neurons restored opiate withdrawal symptoms.
- Endogenous NT-3 was absent in postnatal and adult noradrenergic neurons but present in afferent sources and upregulated in projection areas after chronic morphine exposure.
Conclusions:
- Endogenous NT-3, particularly when expressed by non-catecholaminergic neurons, modulates opiate withdrawal and noradrenergic signaling.
- NT-3 is a critical regulator of noradrenergic pathways involved in opiate withdrawal.
- Targeting NT-3 may offer a novel therapeutic strategy for managing opiate withdrawal.